MedTrace Logo

Identification of Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression

NCT02428439 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-07-05

No results posted yet for this study

Summary

The objective of this study is to identification of genetic markers and predictors of antidepressant-induced suicidality in youth depression. Participants who take the standardized pharmacotherapy (bupropion or lamotrigine) for depression will be observed for 8 weeks. They will do several scales and genetic tests at visit 1 (week 0), visit 3 (week 4) and visit 4 (week 8)

Conditions

Interventions

DRUG

bupropion or lamotrigine

Participants who take the standardized pharmacotherapy (bupropion or lamotrigine) for depression will be observed for 8 weeks. Drugs using in this study are the standard treatment for depression, and are NOT administered as part of this study.

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Hyowon Kim, Professor · Asan Medical Center

Eligibility

Min Age
11 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2019-12-31
Completion
2020-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02428439 on ClinicalTrials.gov